PCI Biotech Holding ASA
OSL: PCIB.OL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Oslo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ronny Skuggedal
- Employees
- 5
- Headquarters
- Oslo, Norway
- IPO year
- 2008
- Market cap
- NOK 2.6M
- Website
- https://www.pcibiotech.com
Loading PCIB…
Loading profile data…Frequently asked questions about PCIB
What does PCI Biotech Holding ASA (PCIB.OL) do?
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell i...
Where does PCIB.OL trade?
PCI Biotech Holding ASA (PCIB.OL) trades on the Oslo Stock Exchange.
What sector is PCIB.OL in?
PCI Biotech Holding ASA (PCIB.OL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PCI Biotech Holding ASA?
Ronny Skuggedal is the chief executive officer of PCI Biotech Holding ASA (PCIB.OL).
Where is PCI Biotech Holding ASA headquartered?
PCI Biotech Holding ASA is headquartered in Norway.
Does PCIB.OL pay a dividend?
PCI Biotech Holding ASA (PCIB.OL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PCIB.OL go public?
PCI Biotech Holding ASA (PCIB.OL) completed its initial public offering in 2008.